GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Prostate | QC | Not yet recruiting
190211_1
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
Sylvie Lambert
Start Date: September 1, 2024

NCT #: NCT06363266

SPONSOR: St. Mary's Research Center, Canada

INFO: https://clinicaltrials.gov/study/NCT06363266

CONTACT: Sylvie Lambert

514-398-3685; sylvie.lambert@mcgill.ca

Other Canadian Centers:

1. St. Mary's Hospital Research Centre (Montreal)

Prostate | BC | Not yet recruiting
H20-02418
Dynamic Whole Body PET/​ MRI
Start Date: August 1, 2024

NCT #: NCT04495959

SPONSOR: British Columbia Cancer Agency

INFO: https://clinicaltrials.gov/study/NCT04495959

CONTACT: Heather Saprunoff 

hsaprunoff@bccancer.bc.ca; 604-877-6000 x 2818

Other Canadian Centres:

1. BC Cancer (Vancouver)

Prostate | ON | Not yet recruiting
SChLAP/IDC Study
Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer (SChLAP/IDC)
Start Date: July 2, 2024

NCT #: NCT04176081

SPONSOR: University Health Network

INFO: https://clinicaltrials.gov/study/NCT04176081

CONTACT: Sunakshi Chowdhary

Sunakshi.Chowdhary@uhn.ca; 416-946-4501 x 5836

Other Canadian Centres:

1. Princess Margaret Hospital (Toronto)

Prostate | ON | Not yet recruiting
dualPET-mPC
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
Di (Maria) Jiang
Start Date: June 1, 2024

NCT #: NCT06335914

SPONSOR: University Health Network

INFO: https://clinicaltrials.gov/study/NCT06335914

CONTACT: Di (Maria) Jiang

416-946-4501 x 4807; di.jiang@uhn.ca

Other Canadian Centres:

1. Princess Margaret Hospital (Toronto)

Renal | ON | Not yet recruiting
4722
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Kristin K Clemens, Louise Moist
Start Date: June 1, 2024

NCT #: NCT06396416

SPONSOR: Western University

INFO: https://clinicaltrials.gov/study/NCT06396416

CONTACT: heather.lapier@sjhc.london.on.ca

Other Canadian Centres:

1. London Health Sciences Centre (London)

Renal | BC | Recruiting
ADVANTage, DAIT CTOT-41
Advancing Transplantation Outcomes in Children (ADVANTage)
David Briscoe, Eileen Chambers
Start Date: May 24, 2024

NCT #: NCT06055608

SPONSOR: National Institute of Allergy and Infectious Diseases (NIAID)

INFO: https://clinicaltrials.gov/study/NCT06055608

CONTACT: Monica Ho (Vancouver): 604-875-2000 x 2485                

Monica.Ho@bcchr.ca

Other Canadian Centres:

1. British Columbia Children's Hospital (Vancouver)

Renal | ON | Not yet recruiting
22-6002
EASE-SOT Pilot Study
Istvan Mucsi
Start Date: May 1, 2024

NCT #: NCT06396702

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/study/NCT06396702

CONTACT: Istvan Mucsi: istvan.mucsi@utoronto.ca                      

416-659-6756

Other Canadian Centres:

1. Toronto General Hospital (Toronto)

Prostate | ON, QC | Recruiting
ASCENDE-SBRT
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Dr. Douglas Andrew Loblaw
Start Date: April 25, 2024

NCT #: NCT06235697

SPONSOR: Canadian Cancer Trials Group.

INFO: https://clinicaltrials.gov/study/NCT06235697

CONTACT: Dr. Douglas Andrew Loblaw

416-480-4806

Other Canadian Centers:

1. Odette Cancer Centre - Sunnybrook Health (Toronto)

2. Trillium Health Partners - Credit Valley Hospital (Toronto)
Dr. Jasper Yuen ; 905-813-4040

3. University Health Network PMH (Toronto)
Dr. Rachel M. Glicksman ; 416-946-4501

4. Jewish General Hospital (Montreal)
Dr. Mohammad T. Niazi ; 514-340-8222 x 8248

Renal | BC, QC | Recruiting
V940-004. & 2023- INTerpath-004
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)
Start Date: April 10, 2024

NCT #: NCT06307431

SPONSOR: Merck Sharp & Dohme LLC

INFO: https://clinicaltrials.gov/study/NCT06307431

CONTACT: Trialsites@merck.com

Other Canadian Centres:

1. CHU de Quebec - Universite Laval (Quebec City)

2. Vancouver BC  ; 604-877-6000

Bladder | BC, ON, QC | Recruiting
GUTPEMV940
"A Clinical Study of V940 Tratment and Pembrolizumab in People With Bladder Cancer (V940-005/​INTerpath-005) "
n/a
Start Date: March 28, 2024

NCT #: NCT06305767

SPONSOR: Merck Sharp & Dohme LLC

INFO: https://clinicaltrials.gov/study/NCT06305767

CONTACT:

1-888-577-8839; Trialsites@msd.com

Other Canadian Centers:

1. BC Cancer Vancouver  2.  Princess Margaret Centree (Toronto)  3. Hôpital de l'Enfant-Jésus (Quebec City)   4. Sherbrooke (Quebec)

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy